Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04471038 · ClinicalTrials.gov registry record · Phase 1

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

A Phase 1 study of Influenza and Influenza Type B, sponsored by SAb Biotherapeutics.

Completed
Registry status
Phase 1
Development phase
27
Enrollment target
1
Study location

NCT04471038 is a Phase 1 study of Influenza and Influenza Type B that has completed, run by SAb Biotherapeutics. The registered enrollment target is 27 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04471038, a Phase 1 study of Influenza and Influenza Type B, has completed, sponsored by SAb Biotherapeutics.

COMPLETED
Registry status
Phase 1
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

Influenza causes substantial morbidity and mortality worldwide despite available antivirals and vaccines. SAB Biotherapeutics, Inc. has developed SAB-176, an anti-influenza human immunoglobulin (transchromosomic \[Tc\] bovine-derived) intravenous therapeutic to treat past and current strains of Type A Influenza and Type B Influenza. This study will evaluate the safety, tolerability, and pharmacokinetics of SAB-176 in healthy participants.

Conditions Studied

Influenza Influenza Type B Influenza Type A

Interventions

  • OTHER Normal Saline
  • BIOLOGICAL SAB-176

Study Locations (1)

Texas

  • PPD, Phase 1 Clinic - Austin

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2020-07-29
Est. Completion 2021-04-19
Phase Phase 1

Sponsor

SAb Biotherapeutics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04471038

The ClinicalTrials.gov registry entry for NCT04471038 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is SAb Biotherapeutics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline is the first listed.

NCT04471038 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04471038 about?

NCT04471038 is a clinical study titled "Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants". Influenza causes substantial morbidity and mortality worldwide despite available antivirals and vaccines. SAB Biotherapeutics, Inc. has developed SAB-176, an anti-influenza human immunoglobulin (transchromosomic \[Tc\] bovine-derived) intravenous therapeutic to treat past and current strains of Type...

What is the current status of trial NCT04471038?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2020-07-29. Estimated completion is 2021-04-19.

What conditions does trial NCT04471038 study?

This clinical trial studies the following conditions: Influenza, Influenza Type B, Influenza Type A.

What interventions are being tested in trial NCT04471038?

The interventions under investigation include: Normal Saline (OTHER), SAB-176 (BIOLOGICAL).

Who is sponsoring clinical trial NCT04471038?

This trial is sponsored by SAb Biotherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04471038 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Influenza

All registered trials for this condition

Influenza Type B

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.